Pharma Journalist - Page 659 of 835 -

Zai Lab’s ZL-1310 Earns FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment

Cellipont Bioservices to Manufacture Master Cell Bank for Secretome Therapeutics’ Lead Asset STM-01

Glox Therapeutics Secures Share of £3M Funding to Combat Antibiotic Resistance in Cystic Fibrosis

Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development

Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria

Astellas Announces Sale of Certain Agensys Research Facilities to Kite

ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project

Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials

Artificial antimicrobial peptides could help overcome drug-resistant bacteria

GE’s new factory-in-a-box accelerates the production of viral vector based therapeutics

Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine

SAMDI Tech Expands Small Molecule Compound Libraries Through Partnership with Enamine

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion